General medical journalCurrentEndo coverage
NEJM Evidence
What CurrentEndo has captured from this journal. The coverage figures describe CurrentEndo's coverage, not the journal's output. Figures as of 14 November 2026.
CurrentEndo holds 13 Briefs from NEJM Evidence, most often randomized controlled trials and meta-analyses.
Follow all of it, or only:You follow this. See your week →Explore NEJM Evid with filters →
- Recent
- 2 Briefs
- past 90 days
- Archive
- 13 Briefs
- research published Apr–Sep 2026, Apr 2024 – Jun 2025, Oct–Dec 2023 and Jan–Mar 2023
- Editorial
- –
- no Weekly issue published yet
Topics
- T2D & otherin Explore215.4%
- T1Din Explore215.4%
- Technologyin Explore215.4%
- Complicationsin Explore17.7%
- Diabetes in pregnancyin Explore17.7%
- Obesityin Explore215.4%
- Adrenalin Explore17.7%
- Reproductive endocrinein Explore17.7%
- Pediatricin Explore17.7%
Evidence types
- Randomized controlled trials969.2%
- Meta-analyses17.7%
- Cohort studies17.7%
- Diagnostic & prognostic17.7%
- Other research17.7%
Shares are of the 13 Briefs CurrentEndo has covered from NEJM Evid, by primary topic and study type.
Publication activity
- 20264 Briefs
- 20252 Briefs
- 20245 Briefs
- 20232 Briefs
Latest from NEJM Evidence
NEJM Evid
A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia
Randomized controlled trialPediatric
NEJM Evid
Metformin in High Metabolic Risk Pregnancies — A Patient-Level Meta-Analysis
Meta-analysisDiabetes in pregnancy
NEJM Evid
Immunotherapy for Fertility in Autoimmune Premature Ovarian Insufficiency
Research articleReproductive endocrine
NEJM Evid
HTD1801 in Combination with Metformin for Type 2 Diabetes
Randomized controlled trialT2D & other
NEJM Evid
Semaglutide in Adults with Type 1 Diabetes and Obesity
Randomized controlled trialT1D
NEJM Evid
Associations between Class I, II, or III Obesity and Health Outcomes
Cohort studyObesity
NEJM Evid
Automated Insulin Delivery in Older Adults with Type 1 Diabetes
Randomized controlled trialTechnology
NEJM Evid
Automated Insulin Delivery for Young People with Type 1 Diabetes and Elevated A1c
Randomized controlled trialTechnology
NEJM Evid
Novel Autologous Dendritic Cell Therapy AVT001 for Type 1 Diabetes
Randomized controlled trialT1D
NEJM Evid
Effect of Fenofibrate on Progression of Diabetic Retinopathy
Randomized controlled trialComplications
NEJM Evid
Intranasal Oxytocin for Obesity
Randomized controlled trialObesity
NEJM Evid
Dapagliflozin or Saxagliptin in Pediatric Type 2 Diabetes
Randomized controlled trialT2D & other
NEJM Evid
Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency
Diagnostic or prognostic studyAdrenal